Effect of Subchronic Alcoholization on the Behavior and Monoaminergic Systems of the Brain of Mice with a Predisposition to Depression-Like Behavior

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Depressive disorders and alcohol dependence are among the most common psychopathologies. It is known that disorders in the serotonergic and dopaminergic brain systems functioning lie in the pathogenesis of alcoholism and affective disorders. In this work, we studied the effects of prolonged administration of ethanol (1.5 g/kg, 20%, 10 days, i.p.) on behavior, functional activity of 5-HT1A and 5-HT2A receptors and expression of genes encoding serotonin (Htr1a, Htr2a) and dopamine (Drd1, Drd2) receptors in brain structures in mice of ASC strain (with the genetic predisposition to depressive-like behavior) and mice of the parental (“non-depressive”) CBA strain. It has been shown that alcoholization leads to an increase in motor activity in animals of both lines and an increase in the level of exploratory behavior in ASC mice. No significant effect of ethanol on social and depression-like behavior was found. The functional activities of 5-HT1A and 5-HT2A receptors (determined by the response to the administration of corresponding receptor agonists) were reduced by ethanol only in ASC animals. A decrease in 5-HT2A receptor gene expression was found in the frontal cortex of CBA mice treated with alcohol. At the same time, ethanol led to an increase in the mRNA levels of the 5-HT1A receptor gene in the striatum and the DRD1 receptor gene in the hypothalamus, as well as a decrease in the expression of the DRD2 receptor gene in the hippocampus of ASC mice. Thus, changes in the serotonergic and dopaminergic brain systems induced by chronic ethanol were more significant in ASC mice with a genetic predisposition to depression-like behavior.

About the authors

D. V. Bazovkina

Institute of Cytology and Genetics, Siberian Division, Russian Academy of Sciences

Email: nchjournal@gmail.com
Russia, Novosibirsk

E. M. Kondaurova

Institute of Cytology and Genetics, Siberian Division, Russian Academy of Sciences

Email: nchjournal@gmail.com
Russia, Novosibirsk

S. N. Adonina

Institute of Cytology and Genetics, Siberian Division, Russian Academy of Sciences

Email: nchjournal@gmail.com
Russia, Novosibirsk

E. Yu. Bazhenova

Institute of Cytology and Genetics, Siberian Division, Russian Academy of Sciences

Email: nchjournal@gmail.com
Russia, Novosibirsk

A. V. Kulikov

Institute of Cytology and Genetics, Siberian Division, Russian Academy of Sciences

Email: nchjournal@gmail.com
Russia, Novosibirsk

References

  1. Boden J.M., Fergusson D.M. // Addiction (Abingdon, England). 2011. V. 106. P. 906–914.
  2. Agabio R., Trogu E., Pani P.P. // The Cochrane Database of Systematic Reviews. 2018. V. 4. CD008581.
  3. McHugh R.K., Weiss R.D. // Alcohol Research: Current Reviews. 2019. V. 40. arcr.v40.1.01.
  4. Stephen Rich J., Martin P.R. // Co-occurring psychiatric disorders and alcoholism / Handbook of Clinical Neurology, 2014. P. 573–588.
  5. Ngui H.H.L., Kow A.S.F., Lai S., Tham C.L., Ho Y.C., Lee M.T. // International Journal of Molecular Sciences. 2022. V. 23. P. 14912.
  6. McIntosh C., Chick J. // Journal of Neurology, Neurosurgery, and Psychiatry. 2004. V. 75. Suppl. 3. P. iii16–iii21.
  7. Nutt D.J. // The Journal of Clinical Psychiatry. 2006. V. 67. Suppl. 6. P. 3–8.
  8. Marcinkiewcz C.A. // ACS Chem. Neurosci. 2015. V. 6. P. 1026–1039.
  9. Kraus C., Castrén E., Kasper S., Lanzenberger R. // Neuroscience and Biobehavioral Reviews. 2017. V. 77. P. 317–326.
  10. Wrzosek M., Jakubczyk A., Wrzosek M., Matsumoto H., Łukaszkiewicz J., Brower K.J., Wojnar M. // Pharmacological Reports. 2012. V. 64. P. 449–453.
  11. Underwood M.D., Kassir S.A., Bakalian M.J., Galfalvy H., Dwork A.J., Mann J.J., Arango V. // Translational Psychiatry. 2018. V. 8. P. 279.
  12. Morganstern I., Tejani-Butt S. // Neurochemical Research. 2010. V. 35. P. 1708–1715.
  13. Базовкина Д.В., Куликов А.В., Кондаурова Е.М., Попова Н.К. // Генетика. 2005. Т. 41. С. 1222‒1228.
  14. Kulikov A.V., Bazovkina D.V., Kondaurova E.M., Po-pova N.K. // Genes, Brain, and Behavior. 2008. V. 7. P. 506–512.
  15. Альперина Е.Л., Куликов А.В., Попова Н.К., Идова Г.В. // Бюлл. эксп. биол. мед. 2007. Т. 144. P. 188‒190.
  16. Базовкина Д.В., Кондаурова Е.М., Цыбко А.С., Ковецкая А.И., Ильчибаева Т.В., Науменко В.С. // Молекулярная биология. 2017. Т. 51. № 4. С. 647–655.
  17. Duman R.S., Deyama S., Fogaça M.V. // Eur. J. Neurosci. 2021. V. 53. P. 126–139.
  18. Tikhonova M.A., Alperin, E.L., Tolstikova T.G., Bazovkina D.V., Di V.Y., Idova G.V., Kulikov A.V., Popova N.K. // Neuroscience and Behavioral Physiology. 2010. V. 40. P. 521–527.
  19. Naumenko V.S., Kondaurova E.M., Bazovkina D.V., Tsybko A.S., Tikhonova M.A., Kulikov A.V., Popova N.K. // Neuroscience. 2012. V. 214. P. 59‒67.
  20. Базовкина Д.В., Цыбко А.С., Филимонова Е.А., Ильчибаева Т.В., Науменко В.С. // Молекулярная биология. 2016. Т. 50. № 2. С. 302–310.
  21. Куликов А.В., Куликов В.А., Базовкина Д.В. // Журн. Высш. нервн. деят. 2005. Т. 55. № 1. С. 116–122.
  22. Kulikov A.V., Tikhonova M.A., Kulikov V.A. // J. Neurosci. Methods. 2008. V. 170. P. 345–351.
  23. Kulikova E.A., Bazovkina D.V., Antonov Y.V., Akulov A.E., Kulikov A.V., Kondaurova E.M. // Neuroscience Research. 2017. V. 117. P. 14–21.
  24. Kulikova E.A., Moskaliuk V.S., Rodnyy A.Y., Bazovkina D.V. // Advances in Gerontology. 2021. T. 11. № 1. C. 37–43.
  25. Bazovkina D., Naumenko V., Bazhenova E., Kondaurova E. // International Journal of Molecular Sciences. 2021. T. 22. № 21.
  26. Науменко В.С., Куликов А.В. // Молекулярная биология. 2006. Т. 40. № 1. С. 37–44.
  27. Naumenko V.S., Osipova D.V., Kulikov A.V., Kostina E.V. // Journal of Neuroscience Methods. 2008. T. 170. № 2. C. 197–203.
  28. Bao X., Qi C., Liu T., Zheng X. // Behavioural Brain Research. 2021. V. 414. P. 113483.
  29. Kraeuter A.K., Guest P.C., Sarnyai Z. // Methods in Molecular Biology. 2019. V. 1916. P. 99–103.
  30. Wang X., Yu H., Wang C., Liu Y., You J., Wang P., Xu G., Shen H., Yao H., Lan X., Zhao R., Wu X., Zhang G. // Toxicology. 2020. V. 446. P. 152625.
  31. Rath M., Tawfic J., Abrorkhujaeva A., Sowell S., Wu S., Eans S.O., Peris J., McLaughlin J.P., Stevens S.M., Liu B. // Alcohol. 2021. V. 95. P. 25–36.
  32. Blokland A., Prickaerts J., Raaijmakers W. // Physiology & Behavior. 1992. V. 51. P. 245–248.
  33. Cadoni C. // Frontiers in Neuroscience. 2016. V. 10. P. 13.
  34. Varlinskaya E.I., Truxell E., Spear L.P. // Alcohol. 2014. V. 48. P. 433–444.
  35. Pradhan G., Melugin P.R., Wu F., Fang H.M., Weber R., Kroener S. // Psychopharmacology. 2018. V. 235. P. 2027–2040.
  36. Walker B.M., Drimmer D.A., Walker J.L., Liu T., Mathe A.A., Ehlers C.L. // Alcohol. 2010. V. 44. P. 487–493.
  37. Boonlert W., Benya-Aphikul H., Umka Welbat J., Rodsiri R. // Nutrients. 2017. V. 9. P. 931.
  38. Yao H., Shen H., Yu H., Wang C., Ding R., Lan X., Tash D., Wu X., Wang X., Zhang G. // Physiology & Behavior. 2021. V. 234. P. 113387.
  39. Ciccocioppo R., Panocka I., Froldi R., Colombo G., Gessa G.L., Massi M. // Psychopharmacology, 1999. V. 144. P. 151–157.
  40. Sharp T., Barnes, N.M. // Neuropharmacology 2020. V. 177. P. 108155.
  41. Martin K.F., Phillips I., Hearson M., Prow M.R., Heal D.J. // Br. J. Pharmacol. 1992. V. 107. P. 15–21.
  42. Kelaï S., Renoir T., Chouchana L., Saurini F., Hanoun N., Hamon M., Lanfumey L. // Journal of Neurochemistry. 2008. V. 107. P. 1660–1670.
  43. Popova N.K., Ilchibaeva T.V., Antonov E.V., Pershina A.V., Bazovkina D.V., Naumenko V.S. // Alcohol. 2020. V. 87. P. 1–15.
  44. Kinoshita H., Jessop D.S., Roberts D.J., Hishida S., Harbuz M.S. // Pharmacology & Toxicology. 2003. V. 93. P. 100–102.
  45. Burnett E.J., Grant K.A., Davenport A.T., Hemby S.E., Friedman D.P. // Drug and Alcohol Dependence. 2014. V. 136. P. 135–142.
  46. Haleem D.J. // Behavioural Pharmacology. 2015. V. 26. P. 45–58.
  47. Lago T., Davis A., Grillon C., Ernst M. // Brain Res. 2017. V. 1654. P. 177–184.
  48. Poisson C.L., Engel L., Saunders B.T. // Frontiers in Neural Circuits. 2021. V. 15. P. 752420.
  49. Homberg J.R., Molteni R., Calabrese F., Riva M.A. // Neuroscience & Biobehavioral Reviews. 2014. V. 43. P. 35e47.
  50. Druse M.J., Tajuddin N.F., Ricken J.D. // Alcoholism, Clinical and Experimental Research. 1997. V. 21. V. 1157–1164.
  51. Le Foll B., Gallo A., Le Strat Y., Lu L., Gorwood, P. // Behavioural Pharmacology. 2009. V. 20. P. 1–17.
  52. Ran X., Yang Y., Meng Y., Li Y., Zhou L., Wang Z., Zhu J. // Journal of Chemical Neuroanatomy. 2019. V. 98. P. 97–103.
  53. Bertoglio L.J., Joca S.R., Guimaraes F.S. // Behav. Brain Res. 2006. V. 175. P. 183–188.
  54. Ebrahimi-Ghiri M., Nasehi M., Zarrindast M.R. // Naunyn-Schmiedeberg’s Archives of Pharmacology. 2018. V. 391. P. 1107–1118.

Supplementary files

Supplementary Files
Action
1. JATS XML
2.

Download (132KB)
3.

Download (63KB)
4.

Download (158KB)
5.

Download (160KB)

Copyright (c) 2023 Д.В. Базовкина, Е.М. Кондаурова, С.Н. Адонина, Е.Ю. Баженова, А.В. Куликов

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies